In Vitro Diagnostics (IVD) News: Breaking In Vitro Diagnostics (IVD) News, Comments and Articles. - Page: 5

19:12 EDT 4th September 2015 | BioPortfolio

In Vitro Diagnostics (IVD) News - Page: 5Twitter RSS

Read the latest In Vitro Diagnostics (IVD) News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on In Vitro Diagnostics (IVD).

Search or Follow Our In Vitro Diagnostics (IVD) - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More In Vitro Diagnostics (IVD) - Page: 5 News.
You can also follow our In Vitro Diagnostics (IVD) - Page: 5 news stories on Twitter: @IVDiagnostics

Showing "invitro diagnostics vitro" News Articles 101 to 125 of 4,100+

Sunday 30th August 2015

$200K awarded to develop in vitro lung test for toxicity of inhaled nanomaterials

(People for the Ethical Treatment of Animals) The PETA International Science Consortium Ltd. announced today the winners of a $200,000 award for the design of an in vitro test to predict the development of lung fibrosis in humans following exposure t...

Viola PE to invest up to $28m in Itamar Medical

The deal will make Viola Private Equity the largest shareholder in the cardiovascular and sleep apnea diagnostics company.

Week in Review: Hepalink Pharma Buys US-based CMO Cytovance

Shenzhen Hepalink Pharma will acquire Cytovance, a US biologics CMO, for $205 million; Shanghai Pharma will launch a $470 million China VC fund for China healthcare startups with partners; DynoSense, a San Jose medical device company, closed a $9.4 m...

Friday 28th August 2015

Foster announces 348 new jobs and £54m investment by Almac Group

Enterprise, Trade and Investment Minister Arlene Foster has announced that the Almac Group is investing over £54 million and creating 348 high quality jobs over the next five years.The Almac Group operates in the pharmaceutical and biotechno...

Critical Outcome Technologies Reports Year-End Financial and Operating Results

LONDON, ON--(Marketwired - August 28, 2015) - Critical Outcome Technologies Inc. ("COTI" or the "Company") (TSX VENTURE: COT) (OTCQB: COTQF) reported its financial and operating results today for the fourth quarter and the year ended April 30, 2015 ("FYE 2015"). Major milestones met during FYE 2015 and year-to-date included: "Key events in fiscal 2015 provided additional validation for COTI-2 a...

Senator Kirk Explores Healthcare Innovation at MATTER

U.S. Senator Mark Kirk (R-IL) today toured healthcare technology incubator MATTER to discuss the future of healthcare with entrepreneurs and industry leaders. Located in Chicago’s Merchandise Mart, MATTER is a community of health technology startups and industry leaders working together to fuel innovation in health IT, medical devices, diagnosti...

Great Basin Scientific to Present at Three Investment Conferences in September

Great Basin Scientific, Inc. (NASDAQ:GBSN), a molecular diagnostics company, announced today that President and CEO Ryan Ashton and CFO Jeffrey Rona will speak at three upcoming investment conferences in New York City, including: Sidoti Emerging Growth Conference on September 2 at 2:50pm E.T. Rodman & Renshaw 17th Annua...

Here Are All the Amicus Briefs That Have Been Filed Seeking En Banc Rehearing of Ariosa v. Sequenom

Yesterday I posted the amici brief I filed on behalf of BIO and PhRMA seeking en banc rehearing of Ariosa v. Sequenom.  Here are links to all twelve amicus briefs that were filed, in one place for your convenience.  Enjoy.  I have not...

Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020

PUNE, India, August 28, 2015 /PRNewswire/ -- According to a new market research report "Cancer Biomarker Market by Tumor (Breast, Lung, Prostate) Type (Protein & Genetic Biomarkers) Profiling Technology (Proteomics, Genomics, Imaging, Immunoassay) Application (Diagnostic, Drug Discovery, Prognostic) & Geography - Global Forecast to 2020", published by MarketsandMarkets, The Cancer Biomark...

Egg Retrieval Earlier in IVF May Let Older Women Conceive for First Time

Women over 43 are generally told it is near-impossible for them to have their own baby, even via IVF (in vitro fertilization).Read more about Egg Retrieval Earlier in IVF May Let Older Wom

BioTime Management to Present at Rodman & Renshaw 17th Annual Global Investment Conference

BioTime, Inc. (NYSE MKT:BTX) announced today that BioTime management will present at the Rodman & Renshaw 17th Annual Investment Conference in New York City from 3:00 to 3:25 p.m. EDT on Thursday, September 10, 2015. Investors will receive an update on BioTime and its subsidiaries. The investor presentation will also be available for a live webcast b...

New White Paper Addresses Common Pre-Analytical Errors in Blood Gas Analysis

Sphere Medical publishes white paper discussing areas where Proxima mitigates sources of pre-analytical errors Sphere Medical, innovator in critical care monitoring and diagnostics equipment, has published a white paper focusing on the mitigation of common pre-analytical errors associated with arterial blood gas analysis [1]. The informative paper is available for download from Sphere’s onli...

WorldCare International, Inc. Celebrates Findings of Independent ROI Study

WorldCare International, Inc.'s online medical consultation offers expert second opinions, which are confirmed to have a high impact on diagnoses and treatments. WorldCare is proud that its services are proven to increase accuracy and reduce overall cost. BOSTON, MA (PRWEB) August 28, 2015 An independent study recently conducted confirms that WorldCare International, Inc.’s online medical c...

Thursday 27th August 2015

Asia's Largest Business Partnering Event - Biotech Industry Key Players from 30 Countries to Gather at BioJapan 2015!

- Drug discovery, regenerative medicine, personalized medicine, functional foods, bio-energy and imaging - BioJapan 2015 will be held for three days from October 14th (Wed) to 16th (Fri), 2015 at Pacifico Yokohama. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150827005023/en/

AAPS PharmSciTech: Co-Amorphous Combination of Nateglinide-Metformin Hydrochloride for Dissolution Enhancement

Type: Original PaperThe aim of the present work was to prepare a co-amorphous mixture (COAM) of Nateglinide and Metformin hydrochloride to enhance the dissolution rate of poorly soluble Nateglinide. Nateglinide (120 mg) and Metformin hydrochloride (...

AAPS PharmSciTech: Effect of Antiadherents on the Physical and Drug Release Properties of Acrylic Polymeric Films

Type: Original PaperAntiadherents are used to decrease tackiness of a polymer coating during both processing and subsequent storage. Despite being a common excipient in coating formulae, antiadherents may affect mechanical properties of the coating f...

AAPS PharmSciTech: In Vitro Anti-inflammatory and Antimicrobial Activities of Azithromycin After Loaded in Chitosan- and Tween 20-Based Oil-in-Water Macroemulsion for Acne Management

Type: Original PaperThe objectives of the current investigation are (1) to prepare and characterize (particle size, surface charge (potential zeta), surface morphology by transmission electron microscopy, drug content, and drug release) the azithromy...

Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments

The Webinar will focus on key performance metrics such as dynamic range, Cq uniformity, sensitivity, and resolution, and review approaches to evaluating these metrics, September 15, 2015. Yorba Linda, CA (PRWEB) August 27, 2015 Workflow in labs has greatly benefitted from the burgeoning array of instruments available for quantitative PCR (qPCR) in the last decade. New features such as multiplexin...

iBIO Institute’s PROPEL Center Awards Grants to 8 Illinois MedTech Companies for AdvaMed 2015

PROPEL Companies Represent 15% of AdvaMed’s Innovation Showcase The PROPEL Center of the iBIO Institute, dedicated to increasing the number and success rate of early-stage life sciences companies in Illinois, announced today that it has awarded 8 grants to help Illinois entrepreneurs attend

Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc.

Cytovance® Biologics, Inc., a Great Point Partners I, LP portfolio company, announced today that it has entered into a definitive agreement to be acquired by Hepalink USA Inc. for $205.68M in cash. GREENWICH, CT and OKLAHOMA CITY, OK (PRWEB) August 27, 2015 Cytovance® Biologics, Inc. (“Cytovance”), a Great Point Partners (“GPP”) I, LP portfolio company and leading biopharmaceuti...

Australia's Anteo Diagnostics to acquire Belgium Dx firm

Biospectrum DIAsource develops clinical diagnostics products in the fields of endocrinology, especially bone metabolism, fertility, cardiovascular and oncology [Read mor...

Great Basin Announces Intent to Settle Certain Warrant Exercises with Cash

Great Basin Scientific, Inc. (NASDAQ:GBSN), a molecular diagnostics company, announced today that it has authorized management at its discretion to settle certain cashless exercises of its Series C Warrants using cash rather than shares, as allowed under the terms of the Series C Warrants. The Series C Warrants were issued as part of the Units of the Compa...

Heart of Texas Veterinary Specialty Center Installs New Veterinary-Specific Small Animal Hyperbaric Chamber

ROUND ROCK, Texas, Aug. 27, 2015 /PRNewswire/ -- Heart of Texas Veterinary Specialty Center located in Round Rock, Texas, installs a new Hyperbaric Veterinary Medicine (hvm) veterinary-specific small animal hyperbaric chamber.   Heart of Texas Veterinary Specialty Center is a 24-hour pet emergency care facility devote...

Biofortuna Launches its New Approach to Custom IVD Manufacture and Development Services

Diagnostics company Biofortuna will mark the 2015 AACC Annual Meeting and Clinical Lab Expo in Atlanta, USA, with the launch of a broader portfolio of custom manufacturing and development services for the IVD market. World-renowned for its lyophilisation services and molecular diagnostic products, Biofortuna has developed a new internal infrastructure, creating distinct products and services divis...

EU OKs fungal test, MDx platform from Renishaw

Regulators in Europe have given Renishaw Diagnostics the CE-IVD mark for its Fungiplex test, a PCR-based assay for analyzing  -More- 



Advertisement
 
Advertisement
 

News Quicklinks